China Universal Asset Management Company’s Krystal Biotech KRYS Stock Holding History

China Universal Asset Management Company’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74M	Sell	4,692 -495	-10%	-$148K	0.1%	145
2026 Q1	$1.34M	Buy	5,187 +462	+10%	+$123K	0.1%	157
2025 Q4	$1.16M	Sell	4,725 -348	-7%	-$73.2K	0.09%	175
2025 Q3	$896K	Sell	5,073 -731	-13%	-$109K	0.07%	189
2025 Q2	$798K	Buy	5,804 +26	+0.4%	+$3.82K	0.08%	193
2025 Q1	$1.04M	Sell	5,778 -320	-5%	-$53.8K	0.1%	180
2024 Q4	$955K	Buy	6,098 +572	+10%	+$101K	0.09%	165
2024 Q3	$1.01M	Buy	5,526 +2,172	+65%	+$419K	0.11%	138
2024 Q2	$616K	Sell	3,354 -2,109	-39%	-$354K	0.09%	131
2024 Q1	$972K	Buy	5,463 +2,204	+68%	+$306K	0.12%	131
2023 Q4	$404K	Buy	3,259 +2,541	+354%	+$282K	0.08%	156
2023 Q3	$83.3K	Buy	718 +379	+112%	+$46.2K	0.02%	207
2023 Q2	$39.8K	Sell	339 -10	-3%	-$1.02K	0.01%	214
2023 Q1	$27.9K	Buy	349 +87	+33%	+$6.83K	0.01%	189
2022 Q4	$20.8K	Buy	262 +22	+9%	+$1.63K	0.01%	171
2022 Q3	$17K	Buy	+240	New	+$17.3K	0.01%	164

Other funds holding KRYS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

China Universal Asset Management Company's KRYS Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Krystal Biotech (KRYS) stake by 9.5% in Q2 2026, selling an estimated $148K and leaving 4,692 shares worth $1.74M. The position accounts for 0.1% of the portfolio, ranked #145.

China Universal Asset Management Company first reported a position in KRYS in Q3 2022 and has held it in 16 quarters since. 267 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

China Universal Asset Management Company held 4,692 shares of Krystal Biotech worth $1.74M as of Q2 2026.
China Universal Asset Management Company sold 495 Krystal Biotech shares in Q2 2026, an estimated $148K.
Krystal Biotech made up 0.1% of China Universal Asset Management Company's portfolio in Q2 2026, its #145 holding.
China Universal Asset Management Company first reported a position in Krystal Biotech in Q3 2022 and has held it in 16 quarters since.
267 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.